Compare Moderna, Inc. (MRNA) vs Open Text Corporation (OTEX) Price & Performance

Moderna, Inc.Trade

Open Text CorporationTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Open Text Corporation — how do they compare? Moderna, Inc. trades at $59.66 (market cap $23.60B), while Open Text Corporation trades at $22.77 (market cap $5.61B). The key difference: Moderna, Inc. is far larger — about 4.2× Open Text Corporation's market cap, and Open Text Corporation pays a 4.72% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

	MRNA	OTEX
Market Cap	$23.60B	$5.61B
Sector	Health	Technology
52-Week High	$81.80	$39.69
52-Week Low	$22.36	$20.01
Enterprise Value	$19.70B	$10.77B
Dividend Yield	—	4.72%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Moderna, Inc.

Moderna (MRNA) trades at $59.66, down 3.49% in the last session amid broader biotech volatility. The stock shows a mixed technical picture with bullish overall signals but bearish moving averages. Fundamentally, revenue has declined from pandemic peaks to $1.92B in 2025, with net losses widening to -$2.82B. Recent positive developments include an EU RSV vaccine contract and progress in cancer immunotherapy trials, with Q2 2026 earnings due July 31.

Outlook remains speculative as Moderna transitions beyond COVID-19 vaccines. Opportunities lie in its expanding pipeline in oncology and flu vaccines, but risks include sustained losses, competitive pressure, and execution hurdles. Analyst consensus is cautious with a $49 price target below current levels, reflecting uncertainty over profitability timeline.

Open Text Corporation

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 14 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

OTEX

Open Text offers 4.7% dividend and buybacks, trading at 11x earnings amid mixed growth and AI risks.Seeking Alpha · 4 days agoBullish OpenText appoints Jill Larsen to board, replacing Kristen Ludgate who resigns for personal reasons.PRNewsWire · 4 days agoBullish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Open Text Corporation

Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.